Domain of cognition - in Schizophrenia and mood disorders - are they relevant? by Pai, Nagesh B
University of Wollongong
Research Online
Faculty of Science, Medicine and Health - Papers Faculty of Science, Medicine and Health
2015
Domain of cognition - in Schizophrenia and mood
disorders - are they relevant?
Nagesh B. Pai
University of Wollongong, nagesh@uow.edu.au
Research Online is the open access institutional repository for the University of Wollongong. For further information contact the UOW Library:
research-pubs@uow.edu.au
Publication Details
N. B. Pai (2015). Domain of cognition - in Schizophrenia and mood disorders - are they relevant?. presented at Third Nitte
International Conference and Workshop on Beyond Symptoms Control, at Nitte Rural Medical and Psychiatric Centre, India, 28
November.
Domain of cognition - in Schizophrenia and mood disorders - are they
relevant?
Abstract
Abstract of a presentation.
Disciplines
Medicine and Health Sciences | Social and Behavioral Sciences
Publication Details
N. B. Pai (2015). Domain of cognition - in Schizophrenia and mood disorders - are they relevant?. presented
at Third Nitte International Conference and Workshop on Beyond Symptoms Control, at Nitte Rural Medical
and Psychiatric Centre, India, 28 November.





Impaired cognition fundamentally impact that primarily affects the ability to function in the 
workplace, at school, or at home. Also, disrupted cognition may prevent severely ill patients 
from deriving full benefit from psychological treatments. The evidence suggests marked 
cognitive impairment predicts poor response to antidepressant medication, independent of 
symptom severity. Among depressed patients, cognitive abnormalities may not resolve 
completely upon remission, and are also observed in first-degree relatives, suggesting that 
they may be trait markers (predisposing factors). 
Cognitive deficits in schizophrenia are pervasive, severe, and largely independent of the 
positive and negative symptoms of the illness. Current schizophrenia treatment has been 
limited in addressing the cognitive deficits of the illness. Although patients with psychotic 
mood disorders may present with a similar pattern of deficits, the magnitude of the deficits in 
schizophrenia is substantially greater. Cognitive performance in schizophrenia appears to be 
stable across fluctuations in illness symptoms, while deficits in affective disorders are more 
closely tied to clinical state. Cognitive deficits in schizophrenia are significantly correlated 
with functional outcome with regards to employment, independent living, community 
functioning, and social functioning. This presentation summarizes the assessment, and 
treatment of negative and cognitive symptoms in patients with schizophrenia and in 
depressive disorders, including pharmacologic and nonpharmacological therapies that can 
be used in clinical care now, as well as pharmacologic approaches that are being tested. 
